Wensi Zhao

Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)

Wensi Zhao, Jun Lei, Shaobo Ke et al. · EClinicalMedicine · 2023 · 95 citations · Full text

Dysbiosis, Phase Ii Trial, Medicine +8

Comparative evaluation of label-free quantification strategies

Lei Zhao, Xiaoji Cong, Linhui Zhai et al. · Journal of Proteomics · 2020 · 55 citations

Natural Language Processing, Engineering, Data Science +9

Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial

Wensi Zhao, Shaobo Ke, Xiaojun Cai et al. · Radiotherapy and Oncology · 2023 · 38 citations

Esophageal Cancer, Phase Ii Trial, Radiation Therapy +9

Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cells

Ziruoyu Wang, Yanan Li, Wensi Zhao et al. · Signal Transduction and Targeted Therapy · 2023 · 33 citations · Full text

Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.

Wensi Zhao, Wanpu Yan, Dongbo Chen et al. · PubMed Central · 2019 · 31 citations · Full text

Genome-scale Crispr Activation, Oncology, Esophageal Cancer +14